EHA joined forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 2nd Sickle Cell & Thalassaemia Virtual Conference.
Registration for the ASCAT meeting has closed.
Dates: January 26-28, 2022
The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.
Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers. All the accepted abstracts have also been published in the abstract book, as an official supplement of HemaSphere.
Please select the most appropriate topic during the abstract & case submission:
- Basic and translational,
- Novel therapies, gene therapies, bone marrow transplant, and emerging diagnostics,
- Clinical and epidemiological studies,
- Infection, autoimmunity, nutritional deficiencies,
- Ageing and end organ damage,
- Health services and outcomes research including psychology.
Accepted abstracts may be presented as an oral presentation or e-poster.
Abstract submission is now closed.
|October 15, 2021||Start abstract & case submission|
|December 14, 2021||Deadline abstract & case submission|
|December 23, 2021||Notification of allocation to authors|
For any questions regarding the abstract submission process, please contact firstname.lastname@example.org.
Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields
Registration is has closed on January 27, 2022/
For more information click here.
The full program can be found here.